Sam Zucker

Sam Zucker is a partner in Goodwin’s Technology Companies and Life Sciences group. He has years of experience working on corporate transactions for high-growth life sciences, healthcare, and technology companies globally, representing investors as well as portfolio companies.

Sam has advised both buyers and sellers in a wide range of mergers and acquisitions, including joint ventures, strategic alliances, collaborations, and divestitures. He also has extensive financing experience, ranging from venture capital, startup, and private equity financings to public company securities offerings such as initial public offerings, follow-ons, confidentially marketed public offerings (CMPOs), registered directs, and private investments in public equity. He also handles regulatory matters involving the U.S. Securities and Exchange Commission and Nasdaq.

In addition, Sam advises management and boards of directors on corporate governance and critical strategic matters – from general corporate, public company reporting, and market regulatory issues to acquisitions, corporate development, and capital market strategies.

Sam has earned several accolades over the course of his career, including the following:

• Chambers USA (2023) for his work in California in Life Sciences: Corporate/Commercial
• Sam has been recognized by The Best Lawyers in America Best Lawyers for his work in Biotechnology and Life Sciences Practice, Corporate Law 2022.
• Chambers and Partners, USA, Leading Lawyer in “Corporate/M&A” and “Life Sciences” sections (2007-2021)
• U.S. News Best Lawyers, Lawyer of the Year 2021 in the areas of biotechnology and life sciences
• Chambers and Partners, Global, Leading Lawyer in “Corporate/M&A” (USA - Foreign Experts; China - Experts Based Abroad)(Spotlight Tables)(2012)
• The Legal 500, Recommended Lawyer in “Capital Markets: Equity Offerings” and “M&A/Corporate and Commercial: Venture Capital and Emerging Companies" categories (2016-2018)
• The Legal 500, Recommended Lawyer in “Capital Markets: Debt Offerings,” “Healthcare: Life Sciences” and “M&A/Corporate and Commercial: Venture Capital and Emerging Companies” categories (2015)
• The Legal 500, Recommended Lawyer in “Healthcare: Life Sciences” and “Mergers, Acquisitions and Buyouts: Venture Capital and Emerging Companies” categories (2014)
• The Legal 500, Recommended Lawyer in “Capital Markets: High-Yield Debt Offerings,” “Healthcare: Life Sciences” and “Venture Capital and Emerging Companies” categories (2013)
• The Legal 500, Recommended Lawyer in “Capital Markets: Equity Offerings,” “Healthcare: Life Sciences” and “Venture Capital and Emerging Companies” categories (2012)
• The Legal 500, Recommended Lawyer in “Mergers, Acquisitions and Buyouts: Venture Capital and Emerging Technology” category (2007–2011)
• Named to the Daily Journal’s 2020 list of Top Healthcare Lawyers
• Named to the Daily Journal’s 2014 list of Top Emerging Companies Lawyers
• Named to the Daily Journal’s 2011 list of the Top 25 Biotech Lawyers in California
• Named to the Daily Journal's 2008 “Top 20 Under 40” list of leading California lawyers under the age of 40
• Named to the Silicon Valley/San Jose Business Journal's 2008 “Top 40 Under 40” list of rising stars in the Silicon Valley business community
• LMG Life Sciences, “Life Sciences Star” for outstanding transactional work (2012–2018)